Zobrazeno 1 - 10
of 54
pro vyhledávání: '"P F, Venter"'
Autor:
Siphamandla Bonga Gumede, John B. F. deWit, Willem D. F. Venter, Annemarie M. J. Wensing, Samanta Tresha Lalla‐Edward
Publikováno v:
Journal of the International AIDS Society, Vol 27, Iss 6, Pp n/a-n/a (2024)
Abstract Introduction Evidence‐based intervention strategies to improve adherence among individuals living with chronic conditions are critical in ensuring better outcomes. In this systematic review, we assessed the impact of interventions that aim
Externí odkaz:
https://doaj.org/article/319193064c1d45669d6ab6d269d02772
Autor:
Aida N. Kawuma, Roeland E. Wasmann, Phumla Sinxadi, Simiso M. Sokhela, Nomathemba Chandiwana, Willem D. F. Venter, Lubbe Wiesner, Gary Maartens, Paolo Denti
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 6, Pp 821-830 (2023)
Abstract Tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) are prodrugs of the nucleotide analogue tenofovir, which acts intracellularly to inhibit HIV replication. Whereas TDF converts to tenofovir in plasma and may cause kidney an
Externí odkaz:
https://doaj.org/article/d0c5aa5d4d6040aa8aeab8553a6989ac
Autor:
Mark J. Siedner, Michelle A. Moorhouse, Bryony Simmons, Tulio de Oliveira, Richard Lessells, Jennifer Giandhari, Stephen A. Kemp, Benjamin Chimukangara, Godspower Akpomiemie, Celicia M. Serenata, Willem D. F. Venter, Andrew Hill, Ravindra K. Gupta
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Here the authors combine next generation sequencing on plasma from participants of the ADVANCE clinical trial with virological and follow-up data to investigate the impact of pre-treatment drug resistance (PDR) to non-nucleoside reverse transcriptase
Externí odkaz:
https://doaj.org/article/1698782bd5904ceaa2191d4ec77b5aff
Autor:
Sarah E. van Riel, Kerstin Klipstein-Grobusch, Roos E. Barth, Diederick E. Grobbee, Charles Feldman, Erica Shaddock, Sarah L. Stacey, Willem D. F. Venter, Alinda G. Vos
Publikováno v:
Southern African Journal of HIV Medicine, Vol 22, Iss 1, Pp e1-e8 (2021)
Background: Studies have associated HIV with an increased risk of obstructive lung disease (OLD). Objectives: We aimed to identify the predictive factors for impaired lung function in an urban, African, HIV-positive population. Method: A cross-sect
Externí odkaz:
https://doaj.org/article/a791b5aab81f477b8c3c762c8d49fba4
Autor:
Alinda G. Vos, Klariska Hoeve, Roos E. Barth, Joyce Peper, Michelle Moorhouse, Nigel J. Crowther, Willem D. F. Venter, Diederick E. Grobbee, Michiel L. Bots, Kerstin Klipstein-Grobusch
Publikováno v:
Retrovirology, Vol 16, Iss 1, Pp 1-10 (2019)
Abstract Background Life expectancy is increasing in the HIV-positive population and age-related non-communicable diseases, such as cardiovascular disease, (CVD) are seen more frequently. This study investigated to what extent HIV and antiretroviral
Externí odkaz:
https://doaj.org/article/3ad6a62633174330ba0923a815686ff2
Autor:
Geert V T Roozen, Ruchika Meel, Joyce Peper, William D F Venter, Roos E Barth, Diederick E Grobbee, Kerstin Klipstein-Grobusch, Alinda G Vos
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0244742 (2021)
BackgroundStudies from high income countries report that HIV-positive people have an impaired systolic and diastolic cardiac function compared to HIV-negative people. It is unclear if results can be translated directly to the Sub-Saharan Africa conte
Externí odkaz:
https://doaj.org/article/a5e4de2372a04eab9271f5292639bb92
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249706 (2021)
BackgroundProlonged hospitalization places a significant burden on healthcare resources. Compared to the general population, hospital length of stay (LOS) is generally longer in HIV-positive patients. We identified predictors of prolonged hospital le
Externí odkaz:
https://doaj.org/article/38962a09b4f14579961f097943c9e4f8
Autor:
E. J. Ketelaar, A. G. Vos, N. G. Godijk, K. Scheuermaier, W. Devillé, H. Tempelmann, R. A. Coutinho, W. D. F. Venter, D. E. Grobbee, K. Klipstein-Grobusch
Publikováno v:
Global Heart, Vol 15, Iss 1 (2020)
Background: The ideal cardiovascular health index (CVHI) is a measure to summarize cardiovascular (CV) health, and includes smoking, body-mass index, physical activity, blood pressure, glucose, total cholesterol, and diet. Objective: This study aimed
Externí odkaz:
https://doaj.org/article/c4ff6e46e70b47529a5a8ba580b627dd
Autor:
Mhairi Maskew, Alana T Brennan, Matthew P Fox, Lungisile Vezi, Willem D F Venter, Peter Ehrenkranz, Sydney Rosen
Publikováno v:
PLoS Medicine, Vol 17, Iss 8, p e1003226 (2020)
BackgroundMany countries encourage same-day initiation of antiretroviral therapy (ART), but evidence on eligibility for same-day initiation, how best to implement it, and its impact on outcomes remains scarce. Building on the Simplified Algorithm for
Externí odkaz:
https://doaj.org/article/d87d5afd1c7d4e1fa973c57f6415fc47
Autor:
Lucas E Hermans, Sergio Carmona, Monique Nijhuis, Hugo A Tempelman, Douglas D Richman, Michelle Moorhouse, Diederick E Grobbee, Willem D F Venter, Annemarie M J Wensing
Publikováno v:
PLoS Medicine, Vol 17, Iss 2, p e1003037 (2020)
BACKGROUND:Uptake of antiretroviral treatment (ART) is expanding rapidly in low- and middle-income countries (LMIC). Monitoring of virological suppression is recommended at 6 months of treatment and annually thereafter. In case of confirmed virologic
Externí odkaz:
https://doaj.org/article/0347ed473be24d5a97a6cb20c7b4718e